These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35868700)

  • 1. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
    Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
    Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
    Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
    Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
    Cheng J; Zheng G; Jin H; Gao X
    Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
    Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
    J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
    Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
    Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
    Che J; Zhao Y; Gu B; Li S; Li Y; Pan K; Sun T; Han X; Lv J; Zhang S; Fan B; Li C; Wang C; Wang J; Zhang T
    BMC Cancer; 2023 Dec; 23(1):1238. PubMed ID: 38102546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
    Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
    J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma.
    Chu LY; Wu FC; Fang WK; Hong CQ; Huang LS; Zou HY; Peng YH; Chen H; Xie JJ; Xu YW
    Biomed J; 2024 Aug; 47(4):100662. PubMed ID: 37774793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
    Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and validation of combined biomarkers for the diagnosis of esophageal intraepithelial neoplasia and esophageal squamous cell carcinoma.
    Zheng YQ; Huang HH; Chen SX; Xu XE; Li ZM; Li YH; Chen SZ; Luo WX; Guo Y; Liu W; Li EM; Xu LY
    J Proteomics; 2024 Jul; 304():105233. PubMed ID: 38925350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
    Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
    J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors.
    Ji L; Wang J; Yang B; Zhu J; Wang Y; Jiao J; Zhu K; Zhang M; Zhai L; Gong T; Sun C; Qin J; Wang G
    Esophagus; 2022 Oct; 19(4):604-616. PubMed ID: 35792948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers.
    Zhu ZJ; Qi Z; Zhang J; Xue WH; Li LF; Shen ZB; Li ZY; Yuan YL; Wang WB; Zhao J
    J Cancer; 2020; 11(13):3944-3954. PubMed ID: 32328198
    [No Abstract]   [Full Text] [Related]  

  • 17. NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection.
    Zhao Y; Ma C; Cai R; Xin L; Li Y; Ke L; Ye W; Ouyang T; Liang J; Wu R; Lin Y
    Nat Commun; 2024 Mar; 15(1):2463. PubMed ID: 38504100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Esophageal Squamous Cell Carcinoma by High-Performance Serum Metabolic Fingerprints: A Retrospective Study.
    Huang Y; Yang H; Li J; Wang F; Liu W; Liu Y; Wang R; Duan L; Wu J; Gao Z; Cao J; Bian F; Zhang J; Zhao F; Yang S; Cao S; Yang A; Wang X; Geng M; Hao A; Li J; Cao J; Li C; Zhang Z; Zhang N; Huang Y; Zhang Y; Qian K; Zhou F
    Small Methods; 2024 Jan; 8(1):e2301046. PubMed ID: 37803160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Omics Analysis Reveals the Role of Changes in Platelet Activation Pathways in the Survival Outcome of Patients with Esophageal Squamous Cell Carcinoma.
    Wang H; Li Z; Yao X; Cheng L; Liu Q; Hu Q; Zhou Q; Yang Q; He H; Cai S; Fang L; Li K; Wang Z; Wen H; Zhou C; Fu M; Cao C
    Altern Ther Health Med; 2024 Oct; 30(10):538-544. PubMed ID: 38401086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of the presence of
    Chen X; Xian B; Wei J; Chen Y; Yang D; Lai X; Liu L; Wu Y; Lin X; Deng Y; Zhang H; Liu W; Qiao G; Li Z
    Front Cell Infect Microbiol; 2022; 12():997333. PubMed ID: 36310858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.